Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
[This corrects the article DOI: 10.1371/journal.pone.0222259.].
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0253671 |
| id |
doaj-2995cf4239874373a2d5d26500aa62c2 |
|---|---|
| record_format |
Article |
| spelling |
doaj-2995cf4239874373a2d5d26500aa62c22021-07-02T04:31:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01166e025367110.1371/journal.pone.0253671Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.Gianluigi GiannelliArmando SantoroRobin K KelleyEd GaneValerie ParadisAnn CleverlyClaire SmithShawn T EstremMichael ManShuaicheng WangMichael M LahnEric RaymondKarim A BenhadjiSandrine Faivre[This corrects the article DOI: 10.1371/journal.pone.0222259.].https://doi.org/10.1371/journal.pone.0253671 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Gianluigi Giannelli Armando Santoro Robin K Kelley Ed Gane Valerie Paradis Ann Cleverly Claire Smith Shawn T Estrem Michael Man Shuaicheng Wang Michael M Lahn Eric Raymond Karim A Benhadji Sandrine Faivre |
| spellingShingle |
Gianluigi Giannelli Armando Santoro Robin K Kelley Ed Gane Valerie Paradis Ann Cleverly Claire Smith Shawn T Estrem Michael Man Shuaicheng Wang Michael M Lahn Eric Raymond Karim A Benhadji Sandrine Faivre Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. PLoS ONE |
| author_facet |
Gianluigi Giannelli Armando Santoro Robin K Kelley Ed Gane Valerie Paradis Ann Cleverly Claire Smith Shawn T Estrem Michael Man Shuaicheng Wang Michael M Lahn Eric Raymond Karim A Benhadji Sandrine Faivre |
| author_sort |
Gianluigi Giannelli |
| title |
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. |
| title_short |
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. |
| title_full |
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. |
| title_fullStr |
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. |
| title_full_unstemmed |
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. |
| title_sort |
correction: biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with tgf-βri inhibitor galunisertib. |
| publisher |
Public Library of Science (PLoS) |
| series |
PLoS ONE |
| issn |
1932-6203 |
| publishDate |
2021-01-01 |
| description |
[This corrects the article DOI: 10.1371/journal.pone.0222259.]. |
| url |
https://doi.org/10.1371/journal.pone.0253671 |
| work_keys_str_mv |
AT gianluigigiannelli correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT armandosantoro correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT robinkkelley correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT edgane correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT valerieparadis correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT anncleverly correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT clairesmith correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT shawntestrem correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT michaelman correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT shuaichengwang correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT michaelmlahn correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT ericraymond correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT karimabenhadji correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib AT sandrinefaivre correctionbiomarkersandoverallsurvivalinpatientswithadvancedhepatocellularcarcinomatreatedwithtgfbriinhibitorgalunisertib |
| _version_ |
1721339998551146496 |